skip to main content


Health Care Reform Impact On The Biotechnology, Pharmaceutical and Medical Device Industries

July 19, 2010

Authors: Donna L. Brooks, Patrick M. Fahey, Joan W. Feldman, Catherine F. Intravia, William J. Roberts

The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the “PPACA”) is a comprehensive reform act that extensively restructures public and private health insurance and the health care industry. The PPACA contains many provisions that directly and indirectly apply to pharmaceutical, biotechnology or medical device companies. In this alert, we have summarized the PPACA’s key provisions affecting the pharmaceutical, biotechnology and medical device industries so that they may identify the applicable opportunities and regulatory requirements. Please click here to view the alert in its entirety.

Related File(s)

Practice Areas

Industries & Featured Services

© Shipman & Goodwin LLP, 2019. All Rights Reserved.